Quick Answer
Black Diamond Therapeutics, Inc. reported Total Assets of $143.01 million for fiscal year 2025.
Black Diamond Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $143.01M | +16.6% |
| 2024 | $122.64M | -22.7% |
| 2023 | $158.57M | +1.5% |
| 2022 | $156.25M | -36.9% |
| 2021 | $247.68M | -24.9% |
| 2020 | $329.67M | +108.3% |
| 2019 | $158.29M | +205.4% |
| 2018 | $51.83M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $157.73M | +14.4% | -5.2% |
| June 30, 2025 | $166.38M | +10.9% | -5.6% |
| March 31, 2025 | $176.25M | +23.7% | +43.7% |
| December 31, 2024 | $122.64M | -22.7% | -11.1% |
| September 30, 2024 | $137.90M | -20.0% | -8.1% |
| June 30, 2024 | $149.99M | +25.1% | +5.2% |
| March 31, 2024 | $142.52M | +5.1% | -10.1% |
| December 31, 2023 | $158.57M | +1.5% | -8.0% |
- Black Diamond Therapeutics, Inc. showed an increase of +16.6% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Black Diamond Therapeutics, Inc.’s total assets has grown by 175.9% (from $51.83 million to $143.01 million).
- The most recent figure is from Black Diamond Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: